| Old | New | Differences | |
|---|---|---|---|
| 1 | - | MISSISSIPPI LEGISLATURE 2025 Regular Session To: Drug Policy By: Representative Barton House Bill 1455 | |
| 1 | + | MISSISSIPPI LEGISLATURE 2025 Regular Session To: Drug Policy By: Representative Barton House Bill 1455 AN ACT TO AMEND SECTION 41-149-7, MISSISSIPPI CODE OF 1972, TO DELETE CERTAIN PROHIBITIONS AGAINST DISTRIBUTORS UNDER THE DEFENDING AFFORDABLE PRESCRIPTION DRUG COSTS ACT; AND FOR RELATED PURPOSES. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MISSISSIPPI: SECTION 1. Section 41-149-7, Mississippi Code of 1972, is amended as follows: 41-149-7. (1) A manufacturer * * *or distributor shall not deny, restrict, prohibit, or otherwise interfere with, either directly or indirectly, the acquisition of a 340B drug by, or delivery of a 340B drug to, a pharmacy that is under contract with a 340B entity and is authorized under such contract to receive and dispense 340B drugs on behalf of the covered entity unless such receipt is prohibited by the United States Department of Health and Human Services. (2) A manufacturer * * *or distributor shall not interfere with a pharmacy contracted with a 340B entity. SECTION 2. This act shall take effect and be in force from and after July 1, 2025. | |
| 2 | 2 | ||
| 3 | 3 | MISSISSIPPI LEGISLATURE | |
| 4 | 4 | ||
| 5 | 5 | 2025 Regular Session | |
| 6 | 6 | ||
| 7 | 7 | To: Drug Policy | |
| 8 | 8 | ||
| 9 | 9 | By: Representative Barton | |
| 10 | 10 | ||
| 11 | 11 | # House Bill 1455 | |
| 12 | 12 | ||
| 13 | - | ## (As Passed the House) | |
| 14 | - | ||
| 15 | 13 | AN ACT TO AMEND SECTION 41-149-7, MISSISSIPPI CODE OF 1972, TO DELETE CERTAIN PROHIBITIONS AGAINST DISTRIBUTORS UNDER THE DEFENDING AFFORDABLE PRESCRIPTION DRUG COSTS ACT; AND FOR RELATED PURPOSES. | |
| 16 | 14 | ||
| 17 | 15 | BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MISSISSIPPI: | |
| 18 | 16 | ||
| 19 | 17 | SECTION 1. Section 41-149-7, Mississippi Code of 1972, is amended as follows: | |
| 20 | 18 | ||
| 21 | 19 | 41-149-7. (1) A manufacturer * * *or distributor shall not deny, restrict, prohibit, or otherwise interfere with, either directly or indirectly, the acquisition of a 340B drug by, or delivery of a 340B drug to, a pharmacy that is under contract with a 340B entity and is authorized under such contract to receive and dispense 340B drugs on behalf of the covered entity unless such receipt is prohibited by the United States Department of Health and Human Services. | |
| 22 | 20 | ||
| 23 | 21 | (2) A manufacturer * * *or distributor shall not interfere with a pharmacy contracted with a 340B entity. | |
| 24 | 22 | ||
| 25 | - | SECTION 2. This act shall take effect and be in force from and after July 1, 2025 | |
| 23 | + | SECTION 2. This act shall take effect and be in force from and after July 1, 2025. |